Global Non-Insulin Hypoglycemic Drug Production, Demand and Key Producers, 2022-2028
This report studies the global Non-Insulin Hypoglycemic Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Insulin Hypoglycemic Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Insulin Hypoglycemic Drug that contribute to its increasing demand across many markets.
The global Non-Insulin Hypoglycemic Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Non-Insulin Hypoglycemic Drug total production and demand, 2017-2028, (K Units)
Global Non-Insulin Hypoglycemic Drug total production value, 2017-2028, (USD Million)
Global Non-Insulin Hypoglycemic Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Non-Insulin Hypoglycemic Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Non-Insulin Hypoglycemic Drug domestic production, consumption, key domestic manufacturers and share
Global Non-Insulin Hypoglycemic Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Non-Insulin Hypoglycemic Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Non-Insulin Hypoglycemic Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Non-Insulin Hypoglycemic Drug market based on the following parameters – headquarters, production locations, products portfolio, Non-Insulin Hypoglycemic Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Insulin Hypoglycemic Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Non-Insulin Hypoglycemic Drug Market, By Region:
1. How big is the global Non-Insulin Hypoglycemic Drug market?
2. What is the demand of the global Non-Insulin Hypoglycemic Drug market?
3. What is the year over year growth of the global Non-Insulin Hypoglycemic Drug market?
4. What is the production and production value of the global Non-Insulin Hypoglycemic Drug market?
5. Who are the key producers in the global Non-Insulin Hypoglycemic Drug market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Non-Insulin Hypoglycemic Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Insulin Hypoglycemic Drug that contribute to its increasing demand across many markets.
The global Non-Insulin Hypoglycemic Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Non-Insulin Hypoglycemic Drug total production and demand, 2017-2028, (K Units)
Global Non-Insulin Hypoglycemic Drug total production value, 2017-2028, (USD Million)
Global Non-Insulin Hypoglycemic Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Non-Insulin Hypoglycemic Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Non-Insulin Hypoglycemic Drug domestic production, consumption, key domestic manufacturers and share
Global Non-Insulin Hypoglycemic Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Non-Insulin Hypoglycemic Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Non-Insulin Hypoglycemic Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Non-Insulin Hypoglycemic Drug market based on the following parameters – headquarters, production locations, products portfolio, Non-Insulin Hypoglycemic Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Insulin Hypoglycemic Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Non-Insulin Hypoglycemic Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Sulfonylureas
- Meglitinides
- Biguanides
- Thiazolidinediones
- Alpha Glucosidase Inhibitors
- Others
- Hospital Pharmacies
- Retail Pharmacies
- GSK
- Eli Lilly
- Sumitomo Dainippon Pharma
- Intarcia Therapeutics
- Servier
- Pfizer
- Merck
- Dong-A Pharmaceutical
- Luye Pharma Group
- Eurofarma
- Geropharm
- Alkem Labs
- Jiangsu Hansoh Pharmaceutical
- Novo Nordisk
- Emisphere
- Uni-Bio Science Group
- Takeda
- 3SBio
- Jiangsu Hengrui Medicine
1. How big is the global Non-Insulin Hypoglycemic Drug market?
2. What is the demand of the global Non-Insulin Hypoglycemic Drug market?
3. What is the year over year growth of the global Non-Insulin Hypoglycemic Drug market?
4. What is the production and production value of the global Non-Insulin Hypoglycemic Drug market?
5. Who are the key producers in the global Non-Insulin Hypoglycemic Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non-Insulin Hypoglycemic Drug Introduction
1.2 World Non-Insulin Hypoglycemic Drug Supply & Forecast
1.2.1 World Non-Insulin Hypoglycemic Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.2.3 World Non-Insulin Hypoglycemic Drug Pricing Trends (2017-2028)
1.3 World Non-Insulin Hypoglycemic Drug Production by Region
1.3.1 World Non-Insulin Hypoglycemic Drug Production Value by Region (2017-2028)
1.3.2 World Non-Insulin Hypoglycemic Drug Production by Region (2017-2028)
1.3.3 World Non-Insulin Hypoglycemic Drug Average Price by Region (2017-2028)
1.3.4 North America Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.3.5 Europe Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.3.6 China Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.3.7 Japan Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Insulin Hypoglycemic Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-Insulin Hypoglycemic Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non-Insulin Hypoglycemic Drug Demand (2017-2028)
2.2 World Non-Insulin Hypoglycemic Drug Consumption by Region
2.2.1 World Non-Insulin Hypoglycemic Drug Consumption by Region (2017-2022)
2.2.2 World Non-Insulin Hypoglycemic Drug Consumption Forecast by Region (2023-2028)
2.3 United States Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.4 China Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.5 Europe Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.6 Japan Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.7 South Korea Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.8 ASEAN Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.9 India Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
3 WORLD NON-INSULIN HYPOGLYCEMIC DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Non-Insulin Hypoglycemic Drug Production Value by Manufacturer (2017-2022)
3.2 World Non-Insulin Hypoglycemic Drug Production by Manufacturer (2017-2022)
3.3 World Non-Insulin Hypoglycemic Drug Average Price by Manufacturer (2017-2022)
3.4 Non-Insulin Hypoglycemic Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non-Insulin Hypoglycemic Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non-Insulin Hypoglycemic Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Non-Insulin Hypoglycemic Drug in 2021
3.6 Non-Insulin Hypoglycemic Drug Market: Overall Company Footprint Analysis
3.6.1 Non-Insulin Hypoglycemic Drug Market: Region Footprint
3.6.2 Non-Insulin Hypoglycemic Drug Market: Company Product Type Footprint
3.6.3 Non-Insulin Hypoglycemic Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Non-Insulin Hypoglycemic Drug Production Value Comparison
4.1.1 United States VS China: Non-Insulin Hypoglycemic Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Non-Insulin Hypoglycemic Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Non-Insulin Hypoglycemic Drug Production Comparison
4.2.1 United States VS China: Non-Insulin Hypoglycemic Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Non-Insulin Hypoglycemic Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Non-Insulin Hypoglycemic Drug Consumption Comparison
4.3.1 United States VS China: Non-Insulin Hypoglycemic Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Non-Insulin Hypoglycemic Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Non-Insulin Hypoglycemic Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Non-Insulin Hypoglycemic Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Non-Insulin Hypoglycemic Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Non-Insulin Hypoglycemic Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Non-Insulin Hypoglycemic Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Non-Insulin Hypoglycemic Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Insulin Hypoglycemic Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Sulfonylureas
5.2.2 Meglitinides
5.2.3 Biguanides
5.2.4 Thiazolidinediones
5.2.5 Alpha Glucosidase Inhibitors
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Non-Insulin Hypoglycemic Drug Production by Type (2017-2028)
5.3.2 World Non-Insulin Hypoglycemic Drug Production Value by Type (2017-2028)
5.3.3 World Non-Insulin Hypoglycemic Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non-Insulin Hypoglycemic Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.3 Market Segment by Application
6.3.1 World Non-Insulin Hypoglycemic Drug Production by Application (2017-2028)
6.3.2 World Non-Insulin Hypoglycemic Drug Production Value by Application (2017-2028)
6.3.3 World Non-Insulin Hypoglycemic Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Details
7.1.2 GSK Major Business
7.1.3 GSK Non-Insulin Hypoglycemic Drug Product and Services
7.1.4 GSK Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GSK Recent Developments/Updates
7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Eli Lilly
7.2.1 Eli Lilly Details
7.2.2 Eli Lilly Major Business
7.2.3 Eli Lilly Non-Insulin Hypoglycemic Drug Product and Services
7.2.4 Eli Lilly Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Eli Lilly Recent Developments/Updates
7.2.6 Eli Lilly Competitive Strengths & Weaknesses
7.3 Sumitomo Dainippon Pharma
7.3.1 Sumitomo Dainippon Pharma Details
7.3.2 Sumitomo Dainippon Pharma Major Business
7.3.3 Sumitomo Dainippon Pharma Non-Insulin Hypoglycemic Drug Product and Services
7.3.4 Sumitomo Dainippon Pharma Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sumitomo Dainippon Pharma Recent Developments/Updates
7.3.6 Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
7.4 Intarcia Therapeutics
7.4.1 Intarcia Therapeutics Details
7.4.2 Intarcia Therapeutics Major Business
7.4.3 Intarcia Therapeutics Non-Insulin Hypoglycemic Drug Product and Services
7.4.4 Intarcia Therapeutics Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Intarcia Therapeutics Recent Developments/Updates
7.4.6 Intarcia Therapeutics Competitive Strengths & Weaknesses
7.5 Servier
7.5.1 Servier Details
7.5.2 Servier Major Business
7.5.3 Servier Non-Insulin Hypoglycemic Drug Product and Services
7.5.4 Servier Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Servier Recent Developments/Updates
7.5.6 Servier Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Non-Insulin Hypoglycemic Drug Product and Services
7.6.4 Pfizer Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Non-Insulin Hypoglycemic Drug Product and Services
7.7.4 Merck Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Dong-A Pharmaceutical
7.8.1 Dong-A Pharmaceutical Details
7.8.2 Dong-A Pharmaceutical Major Business
7.8.3 Dong-A Pharmaceutical Non-Insulin Hypoglycemic Drug Product and Services
7.8.4 Dong-A Pharmaceutical Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Dong-A Pharmaceutical Recent Developments/Updates
7.8.6 Dong-A Pharmaceutical Competitive Strengths & Weaknesses
7.9 Luye Pharma Group
7.9.1 Luye Pharma Group Details
7.9.2 Luye Pharma Group Major Business
7.9.3 Luye Pharma Group Non-Insulin Hypoglycemic Drug Product and Services
7.9.4 Luye Pharma Group Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Luye Pharma Group Recent Developments/Updates
7.9.6 Luye Pharma Group Competitive Strengths & Weaknesses
7.10 Eurofarma
7.10.1 Eurofarma Details
7.10.2 Eurofarma Major Business
7.10.3 Eurofarma Non-Insulin Hypoglycemic Drug Product and Services
7.10.4 Eurofarma Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Eurofarma Recent Developments/Updates
7.10.6 Eurofarma Competitive Strengths & Weaknesses
7.11 Geropharm
7.11.1 Geropharm Details
7.11.2 Geropharm Major Business
7.11.3 Geropharm Non-Insulin Hypoglycemic Drug Product and Services
7.11.4 Geropharm Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Geropharm Recent Developments/Updates
7.11.6 Geropharm Competitive Strengths & Weaknesses
7.12 Alkem Labs
7.12.1 Alkem Labs Details
7.12.2 Alkem Labs Major Business
7.12.3 Alkem Labs Non-Insulin Hypoglycemic Drug Product and Services
7.12.4 Alkem Labs Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Alkem Labs Recent Developments/Updates
7.12.6 Alkem Labs Competitive Strengths & Weaknesses
7.13 Jiangsu Hansoh Pharmaceutical
7.13.1 Jiangsu Hansoh Pharmaceutical Details
7.13.2 Jiangsu Hansoh Pharmaceutical Major Business
7.13.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Hypoglycemic Drug Product and Services
7.13.4 Jiangsu Hansoh Pharmaceutical Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
7.13.6 Jiangsu Hansoh Pharmaceutical Competitive Strengths & Weaknesses
7.14 Novo Nordisk
7.14.1 Novo Nordisk Details
7.14.2 Novo Nordisk Major Business
7.14.3 Novo Nordisk Non-Insulin Hypoglycemic Drug Product and Services
7.14.4 Novo Nordisk Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Novo Nordisk Recent Developments/Updates
7.14.6 Novo Nordisk Competitive Strengths & Weaknesses
7.15 Emisphere
7.15.1 Emisphere Details
7.15.2 Emisphere Major Business
7.15.3 Emisphere Non-Insulin Hypoglycemic Drug Product and Services
7.15.4 Emisphere Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Emisphere Recent Developments/Updates
7.15.6 Emisphere Competitive Strengths & Weaknesses
7.16 Uni-Bio Science Group
7.16.1 Uni-Bio Science Group Details
7.16.2 Uni-Bio Science Group Major Business
7.16.3 Uni-Bio Science Group Non-Insulin Hypoglycemic Drug Product and Services
7.16.4 Uni-Bio Science Group Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Uni-Bio Science Group Recent Developments/Updates
7.16.6 Uni-Bio Science Group Competitive Strengths & Weaknesses
7.17 Takeda
7.17.1 Takeda Details
7.17.2 Takeda Major Business
7.17.3 Takeda Non-Insulin Hypoglycemic Drug Product and Services
7.17.4 Takeda Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Takeda Recent Developments/Updates
7.17.6 Takeda Competitive Strengths & Weaknesses
7.18 3SBio
7.18.1 3SBio Details
7.18.2 3SBio Major Business
7.18.3 3SBio Non-Insulin Hypoglycemic Drug Product and Services
7.18.4 3SBio Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 3SBio Recent Developments/Updates
7.18.6 3SBio Competitive Strengths & Weaknesses
7.19 Jiangsu Hengrui Medicine
7.19.1 Jiangsu Hengrui Medicine Details
7.19.2 Jiangsu Hengrui Medicine Major Business
7.19.3 Jiangsu Hengrui Medicine Non-Insulin Hypoglycemic Drug Product and Services
7.19.4 Jiangsu Hengrui Medicine Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7.19.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Non-Insulin Hypoglycemic Drug and Key Manufacturers
8.2 Non-Insulin Hypoglycemic Drug Manufacturing Costs
8.3 Non-Insulin Hypoglycemic Drug Production Process
8.4 Non-Insulin Hypoglycemic Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Non-Insulin Hypoglycemic Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Non-Insulin Hypoglycemic Drug Typical Distributors
9.3 Non-Insulin Hypoglycemic Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Non-Insulin Hypoglycemic Drug Introduction
1.2 World Non-Insulin Hypoglycemic Drug Supply & Forecast
1.2.1 World Non-Insulin Hypoglycemic Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.2.3 World Non-Insulin Hypoglycemic Drug Pricing Trends (2017-2028)
1.3 World Non-Insulin Hypoglycemic Drug Production by Region
1.3.1 World Non-Insulin Hypoglycemic Drug Production Value by Region (2017-2028)
1.3.2 World Non-Insulin Hypoglycemic Drug Production by Region (2017-2028)
1.3.3 World Non-Insulin Hypoglycemic Drug Average Price by Region (2017-2028)
1.3.4 North America Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.3.5 Europe Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.3.6 China Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.3.7 Japan Non-Insulin Hypoglycemic Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Insulin Hypoglycemic Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-Insulin Hypoglycemic Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non-Insulin Hypoglycemic Drug Demand (2017-2028)
2.2 World Non-Insulin Hypoglycemic Drug Consumption by Region
2.2.1 World Non-Insulin Hypoglycemic Drug Consumption by Region (2017-2022)
2.2.2 World Non-Insulin Hypoglycemic Drug Consumption Forecast by Region (2023-2028)
2.3 United States Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.4 China Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.5 Europe Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.6 Japan Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.7 South Korea Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.8 ASEAN Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
2.9 India Non-Insulin Hypoglycemic Drug Consumption (2017-2028)
3 WORLD NON-INSULIN HYPOGLYCEMIC DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Non-Insulin Hypoglycemic Drug Production Value by Manufacturer (2017-2022)
3.2 World Non-Insulin Hypoglycemic Drug Production by Manufacturer (2017-2022)
3.3 World Non-Insulin Hypoglycemic Drug Average Price by Manufacturer (2017-2022)
3.4 Non-Insulin Hypoglycemic Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non-Insulin Hypoglycemic Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non-Insulin Hypoglycemic Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Non-Insulin Hypoglycemic Drug in 2021
3.6 Non-Insulin Hypoglycemic Drug Market: Overall Company Footprint Analysis
3.6.1 Non-Insulin Hypoglycemic Drug Market: Region Footprint
3.6.2 Non-Insulin Hypoglycemic Drug Market: Company Product Type Footprint
3.6.3 Non-Insulin Hypoglycemic Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Non-Insulin Hypoglycemic Drug Production Value Comparison
4.1.1 United States VS China: Non-Insulin Hypoglycemic Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Non-Insulin Hypoglycemic Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Non-Insulin Hypoglycemic Drug Production Comparison
4.2.1 United States VS China: Non-Insulin Hypoglycemic Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Non-Insulin Hypoglycemic Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Non-Insulin Hypoglycemic Drug Consumption Comparison
4.3.1 United States VS China: Non-Insulin Hypoglycemic Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Non-Insulin Hypoglycemic Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Non-Insulin Hypoglycemic Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Non-Insulin Hypoglycemic Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Non-Insulin Hypoglycemic Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Non-Insulin Hypoglycemic Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Non-Insulin Hypoglycemic Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Non-Insulin Hypoglycemic Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Insulin Hypoglycemic Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Sulfonylureas
5.2.2 Meglitinides
5.2.3 Biguanides
5.2.4 Thiazolidinediones
5.2.5 Alpha Glucosidase Inhibitors
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Non-Insulin Hypoglycemic Drug Production by Type (2017-2028)
5.3.2 World Non-Insulin Hypoglycemic Drug Production Value by Type (2017-2028)
5.3.3 World Non-Insulin Hypoglycemic Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non-Insulin Hypoglycemic Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.3 Market Segment by Application
6.3.1 World Non-Insulin Hypoglycemic Drug Production by Application (2017-2028)
6.3.2 World Non-Insulin Hypoglycemic Drug Production Value by Application (2017-2028)
6.3.3 World Non-Insulin Hypoglycemic Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Details
7.1.2 GSK Major Business
7.1.3 GSK Non-Insulin Hypoglycemic Drug Product and Services
7.1.4 GSK Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GSK Recent Developments/Updates
7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Eli Lilly
7.2.1 Eli Lilly Details
7.2.2 Eli Lilly Major Business
7.2.3 Eli Lilly Non-Insulin Hypoglycemic Drug Product and Services
7.2.4 Eli Lilly Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Eli Lilly Recent Developments/Updates
7.2.6 Eli Lilly Competitive Strengths & Weaknesses
7.3 Sumitomo Dainippon Pharma
7.3.1 Sumitomo Dainippon Pharma Details
7.3.2 Sumitomo Dainippon Pharma Major Business
7.3.3 Sumitomo Dainippon Pharma Non-Insulin Hypoglycemic Drug Product and Services
7.3.4 Sumitomo Dainippon Pharma Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sumitomo Dainippon Pharma Recent Developments/Updates
7.3.6 Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
7.4 Intarcia Therapeutics
7.4.1 Intarcia Therapeutics Details
7.4.2 Intarcia Therapeutics Major Business
7.4.3 Intarcia Therapeutics Non-Insulin Hypoglycemic Drug Product and Services
7.4.4 Intarcia Therapeutics Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Intarcia Therapeutics Recent Developments/Updates
7.4.6 Intarcia Therapeutics Competitive Strengths & Weaknesses
7.5 Servier
7.5.1 Servier Details
7.5.2 Servier Major Business
7.5.3 Servier Non-Insulin Hypoglycemic Drug Product and Services
7.5.4 Servier Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Servier Recent Developments/Updates
7.5.6 Servier Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Non-Insulin Hypoglycemic Drug Product and Services
7.6.4 Pfizer Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Non-Insulin Hypoglycemic Drug Product and Services
7.7.4 Merck Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Dong-A Pharmaceutical
7.8.1 Dong-A Pharmaceutical Details
7.8.2 Dong-A Pharmaceutical Major Business
7.8.3 Dong-A Pharmaceutical Non-Insulin Hypoglycemic Drug Product and Services
7.8.4 Dong-A Pharmaceutical Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Dong-A Pharmaceutical Recent Developments/Updates
7.8.6 Dong-A Pharmaceutical Competitive Strengths & Weaknesses
7.9 Luye Pharma Group
7.9.1 Luye Pharma Group Details
7.9.2 Luye Pharma Group Major Business
7.9.3 Luye Pharma Group Non-Insulin Hypoglycemic Drug Product and Services
7.9.4 Luye Pharma Group Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Luye Pharma Group Recent Developments/Updates
7.9.6 Luye Pharma Group Competitive Strengths & Weaknesses
7.10 Eurofarma
7.10.1 Eurofarma Details
7.10.2 Eurofarma Major Business
7.10.3 Eurofarma Non-Insulin Hypoglycemic Drug Product and Services
7.10.4 Eurofarma Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Eurofarma Recent Developments/Updates
7.10.6 Eurofarma Competitive Strengths & Weaknesses
7.11 Geropharm
7.11.1 Geropharm Details
7.11.2 Geropharm Major Business
7.11.3 Geropharm Non-Insulin Hypoglycemic Drug Product and Services
7.11.4 Geropharm Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Geropharm Recent Developments/Updates
7.11.6 Geropharm Competitive Strengths & Weaknesses
7.12 Alkem Labs
7.12.1 Alkem Labs Details
7.12.2 Alkem Labs Major Business
7.12.3 Alkem Labs Non-Insulin Hypoglycemic Drug Product and Services
7.12.4 Alkem Labs Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Alkem Labs Recent Developments/Updates
7.12.6 Alkem Labs Competitive Strengths & Weaknesses
7.13 Jiangsu Hansoh Pharmaceutical
7.13.1 Jiangsu Hansoh Pharmaceutical Details
7.13.2 Jiangsu Hansoh Pharmaceutical Major Business
7.13.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Hypoglycemic Drug Product and Services
7.13.4 Jiangsu Hansoh Pharmaceutical Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
7.13.6 Jiangsu Hansoh Pharmaceutical Competitive Strengths & Weaknesses
7.14 Novo Nordisk
7.14.1 Novo Nordisk Details
7.14.2 Novo Nordisk Major Business
7.14.3 Novo Nordisk Non-Insulin Hypoglycemic Drug Product and Services
7.14.4 Novo Nordisk Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Novo Nordisk Recent Developments/Updates
7.14.6 Novo Nordisk Competitive Strengths & Weaknesses
7.15 Emisphere
7.15.1 Emisphere Details
7.15.2 Emisphere Major Business
7.15.3 Emisphere Non-Insulin Hypoglycemic Drug Product and Services
7.15.4 Emisphere Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Emisphere Recent Developments/Updates
7.15.6 Emisphere Competitive Strengths & Weaknesses
7.16 Uni-Bio Science Group
7.16.1 Uni-Bio Science Group Details
7.16.2 Uni-Bio Science Group Major Business
7.16.3 Uni-Bio Science Group Non-Insulin Hypoglycemic Drug Product and Services
7.16.4 Uni-Bio Science Group Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Uni-Bio Science Group Recent Developments/Updates
7.16.6 Uni-Bio Science Group Competitive Strengths & Weaknesses
7.17 Takeda
7.17.1 Takeda Details
7.17.2 Takeda Major Business
7.17.3 Takeda Non-Insulin Hypoglycemic Drug Product and Services
7.17.4 Takeda Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Takeda Recent Developments/Updates
7.17.6 Takeda Competitive Strengths & Weaknesses
7.18 3SBio
7.18.1 3SBio Details
7.18.2 3SBio Major Business
7.18.3 3SBio Non-Insulin Hypoglycemic Drug Product and Services
7.18.4 3SBio Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 3SBio Recent Developments/Updates
7.18.6 3SBio Competitive Strengths & Weaknesses
7.19 Jiangsu Hengrui Medicine
7.19.1 Jiangsu Hengrui Medicine Details
7.19.2 Jiangsu Hengrui Medicine Major Business
7.19.3 Jiangsu Hengrui Medicine Non-Insulin Hypoglycemic Drug Product and Services
7.19.4 Jiangsu Hengrui Medicine Non-Insulin Hypoglycemic Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7.19.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Non-Insulin Hypoglycemic Drug and Key Manufacturers
8.2 Non-Insulin Hypoglycemic Drug Manufacturing Costs
8.3 Non-Insulin Hypoglycemic Drug Production Process
8.4 Non-Insulin Hypoglycemic Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Non-Insulin Hypoglycemic Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Non-Insulin Hypoglycemic Drug Typical Distributors
9.3 Non-Insulin Hypoglycemic Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Non-Insulin Hypoglycemic Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Non-Insulin Hypoglycemic Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Non-Insulin Hypoglycemic Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Region (2017-2022)
Table 5. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Region (2023-2028)
Table 6. World Non-Insulin Hypoglycemic Drug Production by Region (2017-2022) & (K Units)
Table 7. World Non-Insulin Hypoglycemic Drug Production by Region (2023-2028) & (K Units)
Table 8. World Non-Insulin Hypoglycemic Drug Production Market Share by Region (2017-2022)
Table 9. World Non-Insulin Hypoglycemic Drug Production Market Share by Region (2023-2028)
Table 10. World Non-Insulin Hypoglycemic Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Non-Insulin Hypoglycemic Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Non-Insulin Hypoglycemic Drug Major Market Trends
Table 13. World Non-Insulin Hypoglycemic Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Non-Insulin Hypoglycemic Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Non-Insulin Hypoglycemic Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Non-Insulin Hypoglycemic Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Non-Insulin Hypoglycemic Drug Producers in 2021
Table 18. World Non-Insulin Hypoglycemic Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Non-Insulin Hypoglycemic Drug Producers in 2021
Table 20. World Non-Insulin Hypoglycemic Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Non-Insulin Hypoglycemic Drug Company Evaluation Quadrant
Table 22. World Non-Insulin Hypoglycemic Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Non-Insulin Hypoglycemic Drug Production Site of Key Manufacturer
Table 24. Non-Insulin Hypoglycemic Drug Market: Company Product Type Footprint
Table 25. Non-Insulin Hypoglycemic Drug Market: Company Product Application Footprint
Table 26. Non-Insulin Hypoglycemic Drug Competitive Factors
Table 27. Non-Insulin Hypoglycemic Drug New Entrant and Capacity Expansion Plans
Table 28. Non-Insulin Hypoglycemic Drug Mergers & Acquisitions Activity
Table 29. United States VS China Non-Insulin Hypoglycemic Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Non-Insulin Hypoglycemic Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Non-Insulin Hypoglycemic Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Non-Insulin Hypoglycemic Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Non-Insulin Hypoglycemic Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Non-Insulin Hypoglycemic Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Non-Insulin Hypoglycemic Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Non-Insulin Hypoglycemic Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Non-Insulin Hypoglycemic Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Non-Insulin Hypoglycemic Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Non-Insulin Hypoglycemic Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Non-Insulin Hypoglycemic Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Non-Insulin Hypoglycemic Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Non-Insulin Hypoglycemic Drug Production by Type (2017-2022) & (K Units)
Table 49. World Non-Insulin Hypoglycemic Drug Production by Type (2023-2028) & (K Units)
Table 50. World Non-Insulin Hypoglycemic Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Non-Insulin Hypoglycemic Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Non-Insulin Hypoglycemic Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Non-Insulin Hypoglycemic Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Non-Insulin Hypoglycemic Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Non-Insulin Hypoglycemic Drug Production by Application (2017-2022) & (K Units)
Table 56. World Non-Insulin Hypoglycemic Drug Production by Application (2023-2028) & (K Units)
Table 57. World Non-Insulin Hypoglycemic Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Non-Insulin Hypoglycemic Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Non-Insulin Hypoglycemic Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Non-Insulin Hypoglycemic Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Non-Insulin Hypoglycemic Drug Product and Services
Table 64. GSK Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Eli Lilly Major Business
Table 69. Eli Lilly Non-Insulin Hypoglycemic Drug Product and Services
Table 70. Eli Lilly Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Eli Lilly Recent Developments/Updates
Table 72. Eli Lilly Competitive Strengths & Weaknesses
Table 73. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Sumitomo Dainippon Pharma Major Business
Table 75. Sumitomo Dainippon Pharma Non-Insulin Hypoglycemic Drug Product and Services
Table 76. Sumitomo Dainippon Pharma Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 78. Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
Table 79. Intarcia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. Intarcia Therapeutics Major Business
Table 81. Intarcia Therapeutics Non-Insulin Hypoglycemic Drug Product and Services
Table 82. Intarcia Therapeutics Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Intarcia Therapeutics Recent Developments/Updates
Table 84. Intarcia Therapeutics Competitive Strengths & Weaknesses
Table 85. Servier Basic Information, Manufacturing Base and Competitors
Table 86. Servier Major Business
Table 87. Servier Non-Insulin Hypoglycemic Drug Product and Services
Table 88. Servier Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Servier Recent Developments/Updates
Table 90. Servier Competitive Strengths & Weaknesses
Table 91. Pfizer Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Major Business
Table 93. Pfizer Non-Insulin Hypoglycemic Drug Product and Services
Table 94. Pfizer Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Pfizer Recent Developments/Updates
Table 96. Pfizer Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck Non-Insulin Hypoglycemic Drug Product and Services
Table 100. Merck Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Dong-A Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Dong-A Pharmaceutical Major Business
Table 105. Dong-A Pharmaceutical Non-Insulin Hypoglycemic Drug Product and Services
Table 106. Dong-A Pharmaceutical Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Dong-A Pharmaceutical Recent Developments/Updates
Table 108. Dong-A Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 110. Luye Pharma Group Major Business
Table 111. Luye Pharma Group Non-Insulin Hypoglycemic Drug Product and Services
Table 112. Luye Pharma Group Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Luye Pharma Group Recent Developments/Updates
Table 114. Luye Pharma Group Competitive Strengths & Weaknesses
Table 115. Eurofarma Basic Information, Manufacturing Base and Competitors
Table 116. Eurofarma Major Business
Table 117. Eurofarma Non-Insulin Hypoglycemic Drug Product and Services
Table 118. Eurofarma Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Eurofarma Recent Developments/Updates
Table 120. Eurofarma Competitive Strengths & Weaknesses
Table 121. Geropharm Basic Information, Manufacturing Base and Competitors
Table 122. Geropharm Major Business
Table 123. Geropharm Non-Insulin Hypoglycemic Drug Product and Services
Table 124. Geropharm Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Geropharm Recent Developments/Updates
Table 126. Geropharm Competitive Strengths & Weaknesses
Table 127. Alkem Labs Basic Information, Manufacturing Base and Competitors
Table 128. Alkem Labs Major Business
Table 129. Alkem Labs Non-Insulin Hypoglycemic Drug Product and Services
Table 130. Alkem Labs Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Alkem Labs Recent Developments/Updates
Table 132. Alkem Labs Competitive Strengths & Weaknesses
Table 133. Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Jiangsu Hansoh Pharmaceutical Major Business
Table 135. Jiangsu Hansoh Pharmaceutical Non-Insulin Hypoglycemic Drug Product and Services
Table 136. Jiangsu Hansoh Pharmaceutical Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 138. Jiangsu Hansoh Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 140. Novo Nordisk Major Business
Table 141. Novo Nordisk Non-Insulin Hypoglycemic Drug Product and Services
Table 142. Novo Nordisk Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Novo Nordisk Recent Developments/Updates
Table 144. Novo Nordisk Competitive Strengths & Weaknesses
Table 145. Emisphere Basic Information, Manufacturing Base and Competitors
Table 146. Emisphere Major Business
Table 147. Emisphere Non-Insulin Hypoglycemic Drug Product and Services
Table 148. Emisphere Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Emisphere Recent Developments/Updates
Table 150. Emisphere Competitive Strengths & Weaknesses
Table 151. Uni-Bio Science Group Basic Information, Manufacturing Base and Competitors
Table 152. Uni-Bio Science Group Major Business
Table 153. Uni-Bio Science Group Non-Insulin Hypoglycemic Drug Product and Services
Table 154. Uni-Bio Science Group Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Uni-Bio Science Group Recent Developments/Updates
Table 156. Uni-Bio Science Group Competitive Strengths & Weaknesses
Table 157. Takeda Basic Information, Manufacturing Base and Competitors
Table 158. Takeda Major Business
Table 159. Takeda Non-Insulin Hypoglycemic Drug Product and Services
Table 160. Takeda Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Takeda Recent Developments/Updates
Table 162. Takeda Competitive Strengths & Weaknesses
Table 163. 3SBio Basic Information, Manufacturing Base and Competitors
Table 164. 3SBio Major Business
Table 165. 3SBio Non-Insulin Hypoglycemic Drug Product and Services
Table 166. 3SBio Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. 3SBio Recent Developments/Updates
Table 168. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 169. Jiangsu Hengrui Medicine Major Business
Table 170. Jiangsu Hengrui Medicine Non-Insulin Hypoglycemic Drug Product and Services
Table 171. Jiangsu Hengrui Medicine Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 172. Non-Insulin Hypoglycemic Drug Raw Material
Table 173. Key Manufacturers of Non-Insulin Hypoglycemic Drug Raw Materials
Table 174. Non-Insulin Hypoglycemic Drug Typical Distributors
Table 175. Non-Insulin Hypoglycemic Drug Typical Customers
Table 1. World Non-Insulin Hypoglycemic Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Non-Insulin Hypoglycemic Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Non-Insulin Hypoglycemic Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Region (2017-2022)
Table 5. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Region (2023-2028)
Table 6. World Non-Insulin Hypoglycemic Drug Production by Region (2017-2022) & (K Units)
Table 7. World Non-Insulin Hypoglycemic Drug Production by Region (2023-2028) & (K Units)
Table 8. World Non-Insulin Hypoglycemic Drug Production Market Share by Region (2017-2022)
Table 9. World Non-Insulin Hypoglycemic Drug Production Market Share by Region (2023-2028)
Table 10. World Non-Insulin Hypoglycemic Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Non-Insulin Hypoglycemic Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Non-Insulin Hypoglycemic Drug Major Market Trends
Table 13. World Non-Insulin Hypoglycemic Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Non-Insulin Hypoglycemic Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Non-Insulin Hypoglycemic Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Non-Insulin Hypoglycemic Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Non-Insulin Hypoglycemic Drug Producers in 2021
Table 18. World Non-Insulin Hypoglycemic Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Non-Insulin Hypoglycemic Drug Producers in 2021
Table 20. World Non-Insulin Hypoglycemic Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Non-Insulin Hypoglycemic Drug Company Evaluation Quadrant
Table 22. World Non-Insulin Hypoglycemic Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Non-Insulin Hypoglycemic Drug Production Site of Key Manufacturer
Table 24. Non-Insulin Hypoglycemic Drug Market: Company Product Type Footprint
Table 25. Non-Insulin Hypoglycemic Drug Market: Company Product Application Footprint
Table 26. Non-Insulin Hypoglycemic Drug Competitive Factors
Table 27. Non-Insulin Hypoglycemic Drug New Entrant and Capacity Expansion Plans
Table 28. Non-Insulin Hypoglycemic Drug Mergers & Acquisitions Activity
Table 29. United States VS China Non-Insulin Hypoglycemic Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Non-Insulin Hypoglycemic Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Non-Insulin Hypoglycemic Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Non-Insulin Hypoglycemic Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Non-Insulin Hypoglycemic Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Non-Insulin Hypoglycemic Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Non-Insulin Hypoglycemic Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Non-Insulin Hypoglycemic Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Non-Insulin Hypoglycemic Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Non-Insulin Hypoglycemic Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Non-Insulin Hypoglycemic Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Non-Insulin Hypoglycemic Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Non-Insulin Hypoglycemic Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Non-Insulin Hypoglycemic Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Non-Insulin Hypoglycemic Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Non-Insulin Hypoglycemic Drug Production by Type (2017-2022) & (K Units)
Table 49. World Non-Insulin Hypoglycemic Drug Production by Type (2023-2028) & (K Units)
Table 50. World Non-Insulin Hypoglycemic Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Non-Insulin Hypoglycemic Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Non-Insulin Hypoglycemic Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Non-Insulin Hypoglycemic Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Non-Insulin Hypoglycemic Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Non-Insulin Hypoglycemic Drug Production by Application (2017-2022) & (K Units)
Table 56. World Non-Insulin Hypoglycemic Drug Production by Application (2023-2028) & (K Units)
Table 57. World Non-Insulin Hypoglycemic Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Non-Insulin Hypoglycemic Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Non-Insulin Hypoglycemic Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Non-Insulin Hypoglycemic Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Non-Insulin Hypoglycemic Drug Product and Services
Table 64. GSK Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Eli Lilly Major Business
Table 69. Eli Lilly Non-Insulin Hypoglycemic Drug Product and Services
Table 70. Eli Lilly Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Eli Lilly Recent Developments/Updates
Table 72. Eli Lilly Competitive Strengths & Weaknesses
Table 73. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Sumitomo Dainippon Pharma Major Business
Table 75. Sumitomo Dainippon Pharma Non-Insulin Hypoglycemic Drug Product and Services
Table 76. Sumitomo Dainippon Pharma Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 78. Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
Table 79. Intarcia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. Intarcia Therapeutics Major Business
Table 81. Intarcia Therapeutics Non-Insulin Hypoglycemic Drug Product and Services
Table 82. Intarcia Therapeutics Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Intarcia Therapeutics Recent Developments/Updates
Table 84. Intarcia Therapeutics Competitive Strengths & Weaknesses
Table 85. Servier Basic Information, Manufacturing Base and Competitors
Table 86. Servier Major Business
Table 87. Servier Non-Insulin Hypoglycemic Drug Product and Services
Table 88. Servier Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Servier Recent Developments/Updates
Table 90. Servier Competitive Strengths & Weaknesses
Table 91. Pfizer Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Major Business
Table 93. Pfizer Non-Insulin Hypoglycemic Drug Product and Services
Table 94. Pfizer Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Pfizer Recent Developments/Updates
Table 96. Pfizer Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck Non-Insulin Hypoglycemic Drug Product and Services
Table 100. Merck Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Dong-A Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Dong-A Pharmaceutical Major Business
Table 105. Dong-A Pharmaceutical Non-Insulin Hypoglycemic Drug Product and Services
Table 106. Dong-A Pharmaceutical Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Dong-A Pharmaceutical Recent Developments/Updates
Table 108. Dong-A Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 110. Luye Pharma Group Major Business
Table 111. Luye Pharma Group Non-Insulin Hypoglycemic Drug Product and Services
Table 112. Luye Pharma Group Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Luye Pharma Group Recent Developments/Updates
Table 114. Luye Pharma Group Competitive Strengths & Weaknesses
Table 115. Eurofarma Basic Information, Manufacturing Base and Competitors
Table 116. Eurofarma Major Business
Table 117. Eurofarma Non-Insulin Hypoglycemic Drug Product and Services
Table 118. Eurofarma Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Eurofarma Recent Developments/Updates
Table 120. Eurofarma Competitive Strengths & Weaknesses
Table 121. Geropharm Basic Information, Manufacturing Base and Competitors
Table 122. Geropharm Major Business
Table 123. Geropharm Non-Insulin Hypoglycemic Drug Product and Services
Table 124. Geropharm Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Geropharm Recent Developments/Updates
Table 126. Geropharm Competitive Strengths & Weaknesses
Table 127. Alkem Labs Basic Information, Manufacturing Base and Competitors
Table 128. Alkem Labs Major Business
Table 129. Alkem Labs Non-Insulin Hypoglycemic Drug Product and Services
Table 130. Alkem Labs Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Alkem Labs Recent Developments/Updates
Table 132. Alkem Labs Competitive Strengths & Weaknesses
Table 133. Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Jiangsu Hansoh Pharmaceutical Major Business
Table 135. Jiangsu Hansoh Pharmaceutical Non-Insulin Hypoglycemic Drug Product and Services
Table 136. Jiangsu Hansoh Pharmaceutical Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 138. Jiangsu Hansoh Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 140. Novo Nordisk Major Business
Table 141. Novo Nordisk Non-Insulin Hypoglycemic Drug Product and Services
Table 142. Novo Nordisk Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Novo Nordisk Recent Developments/Updates
Table 144. Novo Nordisk Competitive Strengths & Weaknesses
Table 145. Emisphere Basic Information, Manufacturing Base and Competitors
Table 146. Emisphere Major Business
Table 147. Emisphere Non-Insulin Hypoglycemic Drug Product and Services
Table 148. Emisphere Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Emisphere Recent Developments/Updates
Table 150. Emisphere Competitive Strengths & Weaknesses
Table 151. Uni-Bio Science Group Basic Information, Manufacturing Base and Competitors
Table 152. Uni-Bio Science Group Major Business
Table 153. Uni-Bio Science Group Non-Insulin Hypoglycemic Drug Product and Services
Table 154. Uni-Bio Science Group Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Uni-Bio Science Group Recent Developments/Updates
Table 156. Uni-Bio Science Group Competitive Strengths & Weaknesses
Table 157. Takeda Basic Information, Manufacturing Base and Competitors
Table 158. Takeda Major Business
Table 159. Takeda Non-Insulin Hypoglycemic Drug Product and Services
Table 160. Takeda Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Takeda Recent Developments/Updates
Table 162. Takeda Competitive Strengths & Weaknesses
Table 163. 3SBio Basic Information, Manufacturing Base and Competitors
Table 164. 3SBio Major Business
Table 165. 3SBio Non-Insulin Hypoglycemic Drug Product and Services
Table 166. 3SBio Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. 3SBio Recent Developments/Updates
Table 168. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 169. Jiangsu Hengrui Medicine Major Business
Table 170. Jiangsu Hengrui Medicine Non-Insulin Hypoglycemic Drug Product and Services
Table 171. Jiangsu Hengrui Medicine Non-Insulin Hypoglycemic Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 172. Non-Insulin Hypoglycemic Drug Raw Material
Table 173. Key Manufacturers of Non-Insulin Hypoglycemic Drug Raw Materials
Table 174. Non-Insulin Hypoglycemic Drug Typical Distributors
Table 175. Non-Insulin Hypoglycemic Drug Typical Customers
LIST OF FIGURES
Figure 1. Non-Insulin Hypoglycemic Drug Picture
Figure 2. World Non-Insulin Hypoglycemic Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Non-Insulin Hypoglycemic Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 5. World Non-Insulin Hypoglycemic Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Non-Insulin Hypoglycemic Drug Production Market Share by Region (2017-2028)
Figure 8. North America Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 9. Europe Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 10. China Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 11. Japan Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 12. Non-Insulin Hypoglycemic Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Non-Insulin Hypoglycemic Drug Demand (2017-2028) & (K Units)
Figure 15. World Non-Insulin Hypoglycemic Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 17. China Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 22. India Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Non-Insulin Hypoglycemic Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Non-Insulin Hypoglycemic Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Non-Insulin Hypoglycemic Drug Markets in 2021
Figure 26. United States VS China: Non-Insulin Hypoglycemic Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Non-Insulin Hypoglycemic Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Non-Insulin Hypoglycemic Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Non-Insulin Hypoglycemic Drug in United States
Figure 30. Key Producers and Market Share of Non-Insulin Hypoglycemic Drug in China
Figure 31. Key Producers and Market Share of Non-Insulin Hypoglycemic Drug in Rest of World
Figure 32. World Non-Insulin Hypoglycemic Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Type in 2021
Figure 34. Sulfonylureas
Figure 35. Meglitinides
Figure 36. Biguanides
Figure 37. Thiazolidinediones
Figure 38. Alpha Glucosidase Inhibitors
Figure 39. Others
Figure 40. World Non-Insulin Hypoglycemic Drug Production Market Share by Type (2017-2028)
Figure 41. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Type (2017-2028)
Figure 42. World Non-Insulin Hypoglycemic Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 43. World Non-Insulin Hypoglycemic Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 44. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Application in 2021
Figure 45. Hospital Pharmacies
Figure 46. Retail Pharmacies
Figure 47. World Non-Insulin Hypoglycemic Drug Production Market Share by Application (2017-2028)
Figure 48. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Application (2017-2028)
Figure 49. World Non-Insulin Hypoglycemic Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Non-Insulin Hypoglycemic Drug in 2021
Figure 51. Manufacturing Process Analysis of Non-Insulin Hypoglycemic Drug
Figure 52. Non-Insulin Hypoglycemic Drug Industrial Chain
Figure 53. Distribution Channel Breakdown for Non-Insulin Hypoglycemic Drug Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Non-Insulin Hypoglycemic Drug Picture
Figure 2. World Non-Insulin Hypoglycemic Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Non-Insulin Hypoglycemic Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 5. World Non-Insulin Hypoglycemic Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Non-Insulin Hypoglycemic Drug Production Market Share by Region (2017-2028)
Figure 8. North America Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 9. Europe Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 10. China Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 11. Japan Non-Insulin Hypoglycemic Drug Production (2017-2028) & (K Units)
Figure 12. Non-Insulin Hypoglycemic Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Non-Insulin Hypoglycemic Drug Demand (2017-2028) & (K Units)
Figure 15. World Non-Insulin Hypoglycemic Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 17. China Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 22. India Non-Insulin Hypoglycemic Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Non-Insulin Hypoglycemic Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Non-Insulin Hypoglycemic Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Non-Insulin Hypoglycemic Drug Markets in 2021
Figure 26. United States VS China: Non-Insulin Hypoglycemic Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Non-Insulin Hypoglycemic Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Non-Insulin Hypoglycemic Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Non-Insulin Hypoglycemic Drug in United States
Figure 30. Key Producers and Market Share of Non-Insulin Hypoglycemic Drug in China
Figure 31. Key Producers and Market Share of Non-Insulin Hypoglycemic Drug in Rest of World
Figure 32. World Non-Insulin Hypoglycemic Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Type in 2021
Figure 34. Sulfonylureas
Figure 35. Meglitinides
Figure 36. Biguanides
Figure 37. Thiazolidinediones
Figure 38. Alpha Glucosidase Inhibitors
Figure 39. Others
Figure 40. World Non-Insulin Hypoglycemic Drug Production Market Share by Type (2017-2028)
Figure 41. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Type (2017-2028)
Figure 42. World Non-Insulin Hypoglycemic Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 43. World Non-Insulin Hypoglycemic Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 44. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Application in 2021
Figure 45. Hospital Pharmacies
Figure 46. Retail Pharmacies
Figure 47. World Non-Insulin Hypoglycemic Drug Production Market Share by Application (2017-2028)
Figure 48. World Non-Insulin Hypoglycemic Drug Production Value Market Share by Application (2017-2028)
Figure 49. World Non-Insulin Hypoglycemic Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Non-Insulin Hypoglycemic Drug in 2021
Figure 51. Manufacturing Process Analysis of Non-Insulin Hypoglycemic Drug
Figure 52. Non-Insulin Hypoglycemic Drug Industrial Chain
Figure 53. Distribution Channel Breakdown for Non-Insulin Hypoglycemic Drug Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
